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ABSTRACT 26 
Aspiration of bile into the cystic fibrosis (CF) lung has emerged as a prognostic factor for 27 
reduced microbial lung biodiversity and the establishment of often fatal, chronic pathogen 28 
infections. Staphylococcus aureus is one of the earliest pathogens detected in the lungs of 29 
children with CF, and once established as a chronic infection, strategies for its eradication 30 
become limited. Several lung pathogens are stimulated to produce biofilms in vitro in the 31 
presence of bile. In this study, we further investigated the effects of bile on S. aureus biofilm 32 
formation. Most clinical S. aureus strains and the laboratory strain RN4220 were stimulated to 33 
form biofilms with sub-inhibitory concentrations of bile. Additionally, we observed bile-34 
induced sensitivity to aminoglycosides, which we exploited in a bursa aurealis transposon 35 
screen to isolate mutants reduced in aminoglycoside sensitivity and augmented in bile-induced 36 
biofilm formation. We identified five mutants that exhibited hypersensitivity to bile with 37 
respect to bile-induced biofilm formation, three of which carried transposon insertions within 38 
gene clusters involved in wall teichoic acid (WTA) biosynthesis or transport. Strain TM4 39 
carried an insertion between the divergently oriented tagH-tagG genes, encoding the putative 40 
WTA membrane translocation apparatus. Ectopic expression of tagG in TM4 restored a wild-41 
type bile-induced biofilm response, suggesting that reduced translocation of WTA in TM4 42 
induced sensitivity to bile and enhanced bile-induced biofilm formation. We propose that WTA 43 
may be important for protecting S. aureus against exposure to bile and that bile-induced biofilm 44 
formation may be an evolved response to protect cells from bile-induced cell lysis. 45 
INTRODUCTION 46 
Chronic infections by pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus 47 
are a leading cause of morbidity and mortality in cystic fibrosis (CF) patients. Chronic bacterial 48 
infections can rarely be eradicated by antimicrobial treatment, and thus chronic infection of the 49 
lung can eventually lead to a fatal decline in lung function (Furukawa et al., 2006). This is 50 
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becoming an ever increasing clinical issue where many have predicted the onset of a post-51 
antibiotic era (Cooper & Shlaes, 2011). Therefore, innovative and alternative strategies are 52 
urgently needed, away from the classical antibiotic approach. The refractory nature of chronic 53 
infections to conventional therapies is largely attributed to bacteria adopting a biofilm-like 54 
mode of growth. Microorganisms in biofilms are embedded within a matrix of extracellular 55 
polymeric substances which provides a barrier against host immune defenses and antimicrobial 56 
therapy (Flemming & Wingender, 2010). The biofilm matrix is composed of polysaccharides, 57 
proteins, lipids, and genomic DNA that is released by lysed resident bacterial cells. While the 58 
molecular mechanisms underlying the formation of biofilms in a broad spectrum of pathogens 59 
has been well studied, until recently the molecular triggers which cause lung-colonizers to 60 
adopt a chronic lifestyle and the associated biofilm mode of growth remained largely 61 
uncharacterized. Understanding how bacteria adopt this chronic lifestyle in the lung would 62 
provide new therapeutic options for prevention and treatment. 63 
The aspiration of bile acids into the lungs arising from gastro-esophageal reflux disease 64 
(GERD) has since emerged as a host-trigger of chronic bacterial infection (Reen et al., 2012; 65 
Reen et al., 2014) and chronic inflammation (Legendre et al., 2014), particularly in CF, where 66 
up to 40% of children and 80% of adult patients can suffer from this complication (Legendre 67 
et al., 2014; Pauwels et al., 2012; Reen et al., 2012; Reen et al., 2014; Stringer et al., 1988). 68 
Indeed, the incidence may be underestimated as clinical diagnosis of GER is often not sufficient 69 
to determine bile aspiration. Bile acids have been detected in the sputum and bronchoalveolar 70 
lavage fluid of patients that do not present with classical GER symptoms. This ‘silent 71 
aspiration’ phenomenon is particularly severe in CF patients and highlights the urgent unmet 72 
need for rapid diagnosis of bile acid profiles in biological samples from respiratory and lung 73 
transplant patients (Button et al., 2005). Over recent years a number of research publications 74 
have suggested that acid-and non-acid reflux may negatively influence the progression of 75 
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respiratory disease (D'Ovidio et al., 2005a; D'Ovidio et al., 2005b; el-Serag & Sonnenberg, 76 
1997; Pauwels et al., 2012; Perng et al., 2007; Wu, 2008; Wu et al., 2009). el-Serag and 77 
Sonnenberg showed that patients with erosive esophagitis, a sign of significant GER, had 78 
increased incidence of pulmonary fibrosis, chronic bronchitis or chronic obstructive pulmonary 79 
disease in a case control study of more than 200,000 patients (el-Serag & Sonnenberg, 1997). 80 
A strong correlation between GER-derived reflux, pulmonary aspiration, and increased lung 81 
damage also extends to several other respiratory diseases (Navarro et al., 2001), including 82 
idiopathic pulmonary disease and advanced lung damage arising from lung transplantation 83 
(Sweet et al., 2006; Sweet et al., 2007a; Sweet et al., 2007b), ventilator associated pneumonia 84 
(Wu et al., 2009), Barrett’s esophagus and esophageal adenocarcinoma (Nassr et al., 2011) and 85 
Bile Acid Pneumonia in neonates (Zecca et al., 2004; Zecca et al., 2008). Therefore, the 86 
implications of elucidating the link between bile aspiration and chronic pathogen behavior has 87 
consequences for a range of clinical conditions. 88 
Apart from an association between GERD and increased colonization by P. aeruginosa 89 
and S. aureus (Palm et al., 2012; van der Doef et al., 2009), bile has been shown to influence 90 
the behavior of P. aeruginosa and other respiratory pathogens in vitro, suppressing phenotypes 91 
associated with acute infection, while up-regulating phenotypes associated with chronic 92 
infection, including biofilm formation (Reen et al., 2012). Microbial diversity has also shown 93 
to be significantly reduced in bile-aspirating patients compared with non-aspirating patients, 94 
suggesting that aspirated bile may be a major factor in shaping the pervasive lung microbiota 95 
signature in CF patients (Blainey et al., 2012; Reen et al., 2014). Furthermore, bile acids have 96 
been shown to trigger the IL-6 pro-inflammatory cytokine in vitro, suppressing HIF-1 signaling 97 
in P. aeruginosa infected cells (Legendre et al., 2014), while reflux and aspiration have been 98 
shown to correlate with increased levels of cytokines and neutrophils in vivo (D'Ovidio et al., 99 
2005a). Therefore, the possibility that the aspiration of bile into the lungs of pediatric patients 100 
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must be considered as a potential underlying factor in the emergence of chronic microbial 101 
infections. 102 
In this study we examined the effect of bile on virulence related behavior in S. aureus, 103 
the primary pathogen associated with early stage CF infection. While S. aureus is considered 104 
a commensal bacterium, as it is a common colonizer of the human skin and respiratory tract, it 105 
is also a frequent cause of clinically important infections (Wertheim et al., 2005). In many 106 
cases S. aureus is the earliest colonizer in CF patients, and is the most prevalent CF pathogen 107 
in children and adolescents (Kahl, 2010; Souza et al., 2006). First elucidating the impact of 108 
physiologically relevant concentrations of bile exposure on this important pediatric pathogen, 109 
we focused on antibiotic tolerance and biofilm formation. In order to probe more deeply the 110 
regulatory mechanisms governing the bile-mediated biofilm response, we utilized a random 111 
transposon mutagenesis screen to isolate S. aureus mutants with an altered bile response. This 112 
uncovered a previously unforeseen switch to a biofilm lifestyle by S. aureus in the presence of 113 
bile, with some intriguing insights into the molecular mechanism underpinning this key 114 
pathogenic determinant.  115 
MATERIALS AND METHODS 116 
Bacterial strains, plasmids, and growth conditions 117 
The bacterial strains and plasmids used in this study are outlined in Table 1. S. aureus strains 118 
were cultured at 37°C in Tryptic Soy Broth (TSB; Becton Dickinson) or Tryptic Soy Agar 119 
(TSA; TSB containing 1.5% (w/v) agar). Escherichia coli EPI300 was used as a cloning host, 120 
and was cultured at 37°C in Lysogeny Broth (LB), or LB agar. Where required, media were 121 
supplemented with the following concentrations of antibiotics unless otherwise stated: 100 122 
µg/mL ampicillin, 10 µg/mL chloramphenicol, 2.5 µg/mL tetracycline, 10 µg/mL 123 
erythromycin. Media were supplemented with bovine bile (Sigma-Aldrich), sodium cholate 124 
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(SC; Sigma-Aldrich), sodium deoxycholate (SDC; Sigma-Aldrich), or sodium dodecyl sulfate 125 
(SDS; Amresco) when required. Stock solutions of bile, SC and SDC were prepared in 126 
deionized distilled water and filter sterilized prior to addition to media. 127 
DNA manipulations 128 
S. aureus DNA was extracted from broth using the FavorPrep Blood / Cultured Cell Genomic 129 
DNA Extraction Mini Kit (Favorgen Biotech Corp) following cell lysis with lysostaphin 130 
(Sigma-Aldrich) unless otherwise stated. Electroporation of S. aureus strains was carried out 131 
using the method described by Schenk & Laddaga (1992). PCR products were amplified using 132 
Phusion High-Fidelity DNA Polymerase (New England BioLabs), and purified using the 133 
FavorPrep GEL/PCR Purification Kit (Favorgen Biotech Corp).  134 
Biofilm attachment assay 135 
Stationary-phase cultures of S. aureus cultures were diluted 1:200 in TSB or TSB 136 
supplemented with appropriate treatment, and aliquots transferred to 96-well or 24-well plates. 137 
Following incubation at 37°C, the wells were washed twice in water to remove planktonic cells. 138 
Attached cells (biofilm) were stained with 0.1% (w/v) crystal violet solution, washed twice to 139 
remove unincorporated stain, and solubilized with acetone:ethanol (3:7) before quantification 140 
by measuring the absorbance at 595 nm. At least three independent biological replicates were 141 
performed for each experiment. For each strain of S. aureus, treatment samples were compared 142 
to untreated samples using a two-tailed paired or unpaired Student’s t-test. 143 
Growth analysis 144 
To determine the effects of bile on the growth of S. aureus, stationary-phase cultures of S. 145 
aureus were diluted 1:500 in 25 mL TSB or TSB supplemented with bovine bile. Cultures were 146 
grown at 37°C with agitation at 180 rpm and samples were taken over a 24 hour period and the 147 
optical density (OD) measured at a wavelength of 600 nm. 148 
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Antibiotic sensitivity determinations 149 
For disc diffusion testing, a single colony of S. aureus RN4220 was resuspended in 1 mL of 150 
phosphate buffered saline, and evenly spread on TSA plates or TSA plates containing 0.3% 151 
bile to prepare a lawn culture. Antibiotic discs, containing gentamicin (10 µg), 152 
chloramphenicol (30 µg), ampicillin (10 µg), erythromycin (15 µg), or tetracycline (30 µg), 153 
were placed on the agar, and the plates were incubated at 37°C for 18 hours, following which 154 
the diameter of the inhibition zone was observed. 155 
The minimum inhibitory concentrations (MICs) of the aminoglycosides gentamycin, 156 
streptomycin, neomycin, and kanamycin were determined in duplicate by broth macrodilution 157 
method. Antibiotic solutions (0.12, 0.25, 0.5, 1, 2, 4, 8, 16, 32, 64 µg/mL) were prepared in 158 
TSB or TSB containing 1 mM SC. An inoculum of S. aureus RN4220 was prepared by saline 159 
(0.85% NaCl) suspension of isolated colonies, adjusted to achieve a turbidity equivalent to a 160 
0.5 McFarland standard, and diluted 1:300 in TSB containing 1 mM SC and/or antibiotics such 161 
that the final inoculum was ~5 x 105 colony-forming units (CFU)/mL. Cultures were incubated 162 
overnight at 37°C with shaking. The lowest concentration of antibiotic which inhibited all 163 
visually apparent growth was considered the MIC. 164 
Transposon mutagenesis 165 
Plasmids pBursa and pFA545 were transformed together into S. aureus RN4220 by 166 
electroporation, and transformants were selected on TSA containing chloramphenicol and 167 
tetracycline following incubation at the permissive temperature of 30°C for 48 hours. Resulting 168 
colonies were resuspended in sterile water and incubated at the non-permissive temperature of 169 
43°C for 1 hour before spreading on selective media (TSA containing 1 erythromycin and SDC, 170 
or TSA containing erythromycin, SC, and either gentamycin, neomycin, or kanamycin) to 171 
screen for mutants of interest. 172 
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Determination of site of transposon insertion 173 
Transposon insertion sites were determined by random-primed PCR as described below. 174 
Oligonucleotide primers are listed in Table 2. DNA was purified from transposon mutants 175 
using PrepMan Ultra Sample Preparation Reagent (Life Technologies) following cell lysis with 176 
lysostaphin. PCR was performed using the purified DNA as template, with a random primer 177 
mix (PF106, PF107 and PF108) and a transposon-specific primer (GFP1). A second PCR was 178 
performed using an aliquot of amplified product from the first PCR, with primers GFP2 and 179 
PF109. Following confirmation of the presence of amplified product by gel electrophoresis, 180 
the PCR reactions were purified and subsequently sequenced using primer GFP3. Sequencing 181 
reactions were conducted by the Australian Genome Research Facility. Each sequence was 182 
compared using the National Center for Biotechnology Information (NCBI) nucleotide Basic 183 
Local Alignment Search (BLASTN) tool to the S. aureus NCTC8325 complete genome 184 
(CP000253.1). The location at which the query sequence first matched the subject sequence 185 
was determined as the transposon insertion site. 186 
RESULTS 187 
Bile induces biofilm formation in most S. aureus 188 
Physiological concentrations of bile or bile acids stimulate in vitro biofilm formation in several 189 
lung-colonizing pathogens (Reen et al., 2012). In contrast, bile suppresses biofilm formation 190 
by S. aureus strain NCDO949, a common laboratory strain originally isolated from pleural 191 
fluid. To establish whether NCDO949 bile-response phenotype was representative of S. aureus 192 
strains, biofilm formation was analyzed for pediatric isolates obtained from the CF unit at Cork 193 
University Hospital, Ireland, using the crystal violet attachment assay. In contrast to 194 
NCDO949, biofilm formation was stimulated by bile in these isolates (Fig. 1a). Furthermore, 195 
bile-stimulated biofilm formation was observed for community-acquired MRSA strains 196 
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JKD6159 and MW2 and the common laboratory strain RN4220 (Fig. 1b). In contrast, USA300 197 
strain JE2 did not exhibit bile-induced biofilm formation. Therefore these data suggest like 198 
other lung pathogens, most S. aureus strains are stimulated to form biofilms in the presence of 199 
bile, but, that there is variation in this response amongst strains. 200 
Since the well-characterized and genetically tractable S. aureus strain RN4220 201 
exhibited a similar response to bile as most clinical S. aureus isolates, we further investigated 202 
the effects of the addition of bile on this strain. Analysis of RN4220 growth in TSB broth 203 
culture revealed that the log-phase growth rate was uninhibited by the addition of up to 0.3% 204 
bovine bile (Fig. 1c). Bile acids make up over 50 % of the total solute concentration of bile 205 
(Kristiansen et al., 2007) and their salt equivalents have been implicated in biofilm formation 206 
in P. aeruginosa (Reen et al., 2012). The addition of sodium cholate (SC) (Fig. 2a) or sodium 207 
deoxycholate (SDC) (Fig. 2b) at sub-inhibitory concentrations resulted in a dose dependent 208 
increase in S. aureus biofilm formation, indicating that these individual bile components were 209 
able to induce a similar response to whole bile in S. aureus. Interestingly, addition of 0.1 mM 210 
of the anionic detergent SDS also causes a similar but statistically insignificant increase in 211 
biofilm formation, possibly indicating that the biofilm formation by S. aureus may be a 212 
response to the common detergent activities of these molecules (Fig. 2c). 213 
Development of a bursa aurealis transposon mutagenesis screen to isolate bile-response 214 
mutants 215 
Bile acids have been demonstrated to enhance the activity of penicillin and neomycin against 216 
staphylococcal strains. Bile has no effect on the efficacy of other antibiotics such as 217 
chloramphenicol or erythromycin, but can weaken the activity of some antibiotics including 218 
vancomycin (Schneierson & Amsterdam, 1958; Stanley Schneierson et al., 1962). In a study 219 
which compared the effects of various bile acids in their salt form, as well as other components 220 
of bile such as cholesterol, SC and SDC were found to be the most effective at increasing the 221 
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anti-staphylococcal activity of neomycin (Stanley Schneierson et al., 1962). We investigated 222 
the effect of SC on antibiotic tolerance in S. aureus RN4220. Disc diffusion antibiotic 223 
sensitivity testing revealed that 0.3% bile increased the sensitivity of S. aureus RN4220 224 
towards gentamicin, but had no effect on chloramphenicol, ampicillin, erythromycin or 225 
tetracycline (Fig. S1). We suspected that bile acids may specifically induce sensitivity to 226 
aminoglycosides in S. aureus RN4220. After confirming that SC at a concentration of 1 mM 227 
did not have bactericidal or bacteriostatic effects on this strain (Fig. S2), we proceeded to test 228 
the MIC of gentamycin, streptomycin, neomycin and kanamycin both in the presence of 1mM 229 
SC. The MIC of all aminoglycosides was reduced in the presence of 1 mM SC (Table 3), 230 
consistent with a previous study in Lactobacillus species (Elkins & Mullis, 2004), where the 231 
authors implicated increased antibiotic uptake following bile exposure. 232 
We hypothesized that the molecular control of bile-induced aminoglycoside sensitivity 233 
and bile-induced biofilm formation in S. aureus might be linked at a regulatory level. Following 234 
this hypothesis, we predicted that mutant RN4220 strains that overcame bile-induced 235 
aminoglycoside sensitivity might also exhibit an altered bile-induced biofilm formation 236 
phenotype. In order to isolate genetically marked mutant strains that had overcome bile-237 
induced aminoglycoside sensitivity, we utilized random transposon mutagenesis using the 238 
mariner-based transposon bursa aurealis to generate  pools of mutant RN4220 and then 239 
selected for mutants that had overcome bile-induced aminoglycoside sensitivity in the presence 240 
of 1 mM sodium cholate. A range of aminoglycosides was utilized to avoid bias towards 241 
mutations which conferred resistance via an antibiotic-specific mechanism. Aminoglycoside 242 
concentrations were adjusted in selection plates to a level at which we could observe over ten 243 
colonies per plate. 244 
In multiple rounds of mutagenesis with various aminoglycosides, several hundred S. 245 
aureus mutants were isolated. For 44 mutants we identified the site of the transposon using 246 
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random-primed PCR. Table S1 shows the list of transposon mutants, the antibiotic and 247 
concentration used to screen for the mutant, and the site of transposon insertion. Thirty four of 248 
the mutants carried the transposon insertion within a defined open reading frame (ORF), while 249 
the remaining 10 mutants had the transposon insertion occurring at between two coding 250 
sequences. Where possible the putative gene and/or gene product associated with the 251 
transposon disruption were identified (Table S1). 252 
Regulatory mutations in wall-teichoic acid synthesis stimulate a hypersensitive bile-253 
induced biofilm response 254 
We screened all 44 mapped mutants for differential biofilm formation in response to bile using 255 
the crystal violet assay (Fig. S3). Of these, five exhibited an increased sensitivity to bile, in that 256 
they exhibited increased attachment in the presence of 0.03% bile, compared to wild-type 257 
RN4220. As previously discussed, although the parental RN4420 strain displayed a significant 258 
increase biofilm formation in the presence of 0.3% bile, it failed to respond to bile at the level 259 
of 0.03%. In contrast, five mutants, namely TM4, TM19, TM26, TM28 and TM39, showed an 260 
enhanced bile-response, displaying substantially increased biofilm formation in the presence 261 
of 0.03% bile (Fig. 3), a phenotype akin to several of the clinical isolates investigated. 262 
Of the five mutants that exhibited biofilm stimulation in the presence of 0.03% bile, 263 
three carried the transposon insertion within a defined ORF (TM19, TM26, TM28), while two 264 
had the transposon insertion occurring at between two coding sequences (TM4, TM39). 265 
Interestingly, in both mutants from the latter category, the transposon insertion was between 266 
divergently oriented genes where at least one gene was associated with wall teichoic acid 267 
(WTA) biosynthesis. TM4 carried an insertion between divergently oriented WTA 268 
biosynthesis genes, tagG and tagH (Lazarevic & Karamata, 1995; Schirner et al., 2011). In 269 
TM39 the insertion was between tagO, which is associated with WTA biosynthesis (Soldo et 270 
al., 2002; Xia et al., 2010), and gdpS, the only conserved GGDEF domain protein identified 271 
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thus far in Staphylococcus (Shang et al., 2009). Furthermore, the transposon insertion in TM26 272 
was within tarJ, another gene involved in the WTA biosynthetic pathway (Brown et al., 2013). 273 
It should be noted however, that although the insertion disrupted tarJ, this gene is duplicated 274 
in many S. aureus strains (Qian et al., 2006), and the locus SAOUHSC_00226 in the strain 275 
NCTC8325 most likely represents a second copy of tarJ. These data indicated that WTA 276 
synthesis or its regulation might be involved in the response to bile and control of biofilm 277 
production. The remaining two hypersensitive mutants carried insertions within ctaB (TM19), 278 
which encodes for heme O synthase, and a possible D-galactonate transporter (TM28). 279 
The isolation of mutants in WTA-associated genes suggested that WTA synthesis 280 
and/or translocation were involved in the bile-induced biofilm response, but because two 281 
insertions were within intergenic regions, it was unclear if this was due to increased or 282 
decreased WTA. We PCR-amplified and cloned regions of tagG-tagH from RN4220 into the 283 
S. aureus shuttle vector pLI50, and introduced each clone into both TM4 and wild type 284 
RN4220. While the introduction of pLI50 into RN4220 did not alter its bile-induced biofilm 285 
response, introduction of pLI50 containing carrying tagG (along with the sod ribosomal 286 
binding site (Malone et al., 2009); pLI50::tagG) into TM4 led to the restoration of the wild 287 
type phenotype (Fig. 4). Introduction of a similar construct carrying tagH had no effect (not 288 
shown). Interestingly, introduction of pLI50 containing a copy of the non-coding intergenic 289 
region located between tagH and tagG (pLI50::int_tagHG) into in RN4220, produced a strain 290 
with an almost identical phenotype to TM4 (Fig. 4). Together these data suggest that the 291 
enhanced bile-induced biofilm phenotype in TM4 may be due to a reduced expression of tagG, 292 
caused by the transposon insertion disrupting an operator site for an activator of tagG. The 293 
introduction of pLI50::tagG into TM4 likely restores the expression of tagG independently of 294 
the activator, producing the observed wild type phenotype, while the introduction of the 295 
intergenic region in RN4220 may sequester a DNA-binding activator of tagG expression. 296 
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DISCUSSION 297 
The pathogenesis of S. aureus in the lungs of respiratory patients is characterized by successful 298 
colonization and persistence, particularly in pediatric CF patients where it dominates the early 299 
developing lungs. The environmental factors that cause S. aureus to adopt this pervasive 300 
lifestyle are as yet unknown, but our data presents a strong case for a role for bile aspiration 301 
derived from GERD in the pathogenesis of this organism. In this study we demonstrate that 302 
physiologically relevant concentrations of bile, as well as sub inhibitory concentrations of bile 303 
acids, can alter the behavior of S. aureus, leading to enhanced biofilm formation by this 304 
important clinical pathogen. The biofilm mode of growth is frequently associated with chronic 305 
infections as it allows the bacterium to evade host defenses, and persist for extended periods 306 
of time (Furukawa et al., 2006). Our observation is consistent with the increased incidence of 307 
S. aureus in pediatric patients suffering from GERD (Palm et al., 2012; van der Doef et al., 308 
2009), the likely source of bile acids in the lungs of these patients (Aseeri et al., 2012; Pauwels 309 
et al., 2012; Reen et al., 2014).  310 
This bile-mediated response presented an opportunity to probe more deeply the 311 
regulatory mechanisms governing the switch between the phenotypes associated with acute 312 
and chronic infection in S. aureus. Using a random transposon mutagenesis approach we 313 
identified five S. aureus mutants with an enhanced bile-induced biofilm response. Of these, 314 
three mutants had a transposon insertion within or directly upstream of genes involved in WTA 315 
biosynthesis. WTA are surface-exposed anionic glycopolymers present in many gram positive 316 
species of bacteria, covalently bound to the peptidoglycan layer (Brown et al., 2013). Indeed 317 
WTA are the most abundant peptidoglycan bound glycopolymer in gram positive species, 318 
making up over half of the dry weight of the cell wall. WTA have been shown to play key roles 319 
in maintenance of cell shape, several aspects of cell division, modulation of antibiotic 320 
susceptibility, and host tissue colonization (Swoboda et al., 2010; Weidenmaier et al., 2004). 321 
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Moreover, WTA have been implicated in biofilm formation in staphylococcal species (Holland 322 
et al., 2011; Vergara-Irigaray et al., 2008). For example, WTA contain D-alanine modifications 323 
which allow S. aureus to modulate its surface charge, aiding its primary attachment to artificial 324 
surfaces before the formation of multiple cell layers (Gross et al., 2001). 325 
S. aureus WTA polymers are composed of 30-50 ribitol phosphate (Rbo-P) subunits, 326 
connected to peptidoglycan via the murein linkage unit GlcNAc-ManNAc-(glycerol phosphate 327 
[Gro-P])2-3 (Yokoyama et al., 1986). WTA biosynthesis is a complex multi-step process which 328 
is yet to be fully characterized (Brown et al., 2013). However, it has been shown that tagO, the 329 
regulatory region of which is likely disrupted in TM39, is involved in initiating the synthesis 330 
of the aforementioned murein linkage unit (Soldo et al., 2002; Xia et al., 2010). TarJ (an 331 
alcohol dehydrogenase), the function of which is most likely abrogated in TM26, together with 332 
TarI and TarL, catalyzes the attachment of Rbo-P to the murein linkage unit. Once WTA 333 
polymer formation is complete, it is translocated across the plasma membrane by the two-334 
component ABC (ATP-binding cassette) transporter TagGH (Lazarevic & Karamata, 1995; 335 
Schirner et al., 2011), the regulatory region of which was mutated in TM4. TagG presumably 336 
facilitates translocation of WTA polymer across the plasma membrane following a 337 
conformational change in the transmembrane domain induced by TagH. 338 
The occurrence of three independent mutations within or flanking genes involved in the 339 
WTA biosynthesis pathway leading to enhanced biofilm formation in the presence of bile, 340 
strongly suggests an involvement of WTA in the S. aureus bile-induced biofilm formation 341 
response. WTA are essential for biofilm formation and host-colonization by S. aureus (Gross 342 
et al., 2001; Weidenmaier et al., 2004), and deletion of tagO impairs biofilm production in 343 
Staphylococcus epidermidis (Holland et al., 2011). Interestingly, none of our isolated mutants 344 
carried complete knockouts in genes essential for WTA biosynthesis. Mutants TM4 and TM39 345 
carried intergenic insertions, while in TM26 the insertion was in one of two tarJ genes in S. 346 
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aureus (Qian et al., 2006). This pattern of insertions is consistent with bias against WTA-347 
associated insertions in the Nebraska Transposon Mutant Library, which consists of 1,952 348 
strains, each containing a single mutation within a nonessential gene of S. aureus isolate 349 
USA300. This collection also lacks mutations within tagO, tagG, and tagH, suggesting these 350 
may be essential genes (Fey et al., 2013). Thus the mutations within the hyper-biofilm mutants 351 
likely do not knock out WTA synthesis, but may merely reduce it and concomitantly induce 352 
sensitivity to bile, leading to an increased level of biofilm production on exposure to lower 353 
concentrations of bile. 354 
As bile is known to induce cell membrane damage (Begley et al., 2005), and biofilms 355 
protect microorganisms from external damaging-agents (Flemming & Wingender, 2010), our 356 
observations lead us to propose that the bile-induced biofilm phenotype is an adaptive response 357 
to increased cell wall stress. In line with this, the inhibition of WTA synthesis by deletion of 358 
LytR-CpsA-Psr proteins has been shown to increase the basal expression of the ‘cell wall stress 359 
stimulon’, a collection of genes responsible for mounting a general cell wall stress response in 360 
the presence of cell wall damaging agents (Dengler et al., 2012). The recently discovered 361 
antibiotic targocil, which blocks expression of tagG, has also been shown to induce cell wall 362 
stress in S. aureus (Campbell et al., 2012). It its plausible that in the hyper-biofilm mutants 363 
identified in the present study, the transposon insertions reduce WTA biosynthesis, thereby 364 
stimulating a more profound cell wall stress-response in the presence of bile. 365 
The transposon screen employed by this study utilized an indirect screening approach 366 
to identify genes within regulatory pathways involved in the S. aureus bile-response. This 367 
approach was limited in that all mutations identified as being important in biofilm formation 368 
were a subset of the mutations which conferred aminoglycoside resistance. As such, mutations 369 
which alter the bile-modulated biofilm response, but do not affect bile-induced aminoglycoside 370 
sensitivity, were not able to be detected in this study. As the bile induced aminoglycoside 371 
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sensitivity is likely caused by cell membrane perturbation by bile, leading to increased uptake 372 
of aminoglycosides, it was not surprising to observe a large number of mutations within genes 373 
involved in cell envelope integrity. Despite these limitations, the data presented in this study 374 
provides several insights into the possible regulatory mechanisms governing the bile-response 375 
in S. aureus. Further investigation of these mutants will provide insights into bile-responsive 376 
pathways linking biofilm formation to host-triggers of chronic infection, thereby facilitating 377 
the development of innovative strategies for the prevention and treatment of respiratory 378 
disease. 379 
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FIGURES 622 
Fig. 1  Bile-dependent biofilm formation in Staphylococcus aureus. (a) Pediatric clinical isolates 623 
compared to NCDO949, and (b) Community acquired methicillin-resistant isolates compared to 624 
RN4220. Data is presented as a ratio of the Abs595 nm from treated vs untreated samples. Graphs show 625 
mean (+/- SEM) relative absorbance of at least three independent experiments, each carried out in 626 
triplicate. Statistical analysis was performed by two-tailed paired Student’s t-test (* P < 0.05, ** P < 627 
0.01, compared with untreated control). (c) Growth of S. aureus RN4220 in presence of bovine bile. 628 
Graphs show mean (+/- SD) OD600 nm of two biological replicates. 629 
Fig. 2  Biofilm formation in Staphylococcus aureus RN4220 in response to bile and bile salts. S. 630 
aureus strain RN4220 cultured for 18 h in TSB (untreated), or TSB supplemented with (a) sodium 631 
cholate (SC), (b) sodium deoxycholate (SDC), and (c) sodium dodecyl sulphate (SDS). Graphs show 632 
mean (+/- SD) relative absorbance of three biological replicates. Statistical analysis was performed a 633 
two-tailed unpaired Student’s t-test (* P < 0.05, ** P < 0.01 compared with untreated). 634 
Fig. 3  Altered bile-dependent biofilm formation in Staphylococcus aureus transposon mutants. 635 
Graphs show mean (+/- SD) absorbance from three independent experiments each performed in 636 
triplicate. Statistical analysis was performed a two-tailed paired Student’s t-test (** P < 0.01). 637 
Fig. 4  Complementation of bile induced biofilm phenotype. Transposon mutant TM4 and wild type 638 
RN4220 strains were transformed with plasmid pLI50 containing parts of the tagG-tagH genomic 639 
region from RN4220 (pLI50::int_tagHG, pLI50 containing intergenic region between tagH and tagG; 640 
pLI50::tagG, pLI50 containing tagG). Strains were cultured for 18h in TSB (untreated), or TSB 641 
supplemented 0.03% bile, following which biofilm attachment was measured. Graphs show mean (+/- 642 
SD) absorbance from 3 replicates. 643 
  644 
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TABLES 645 
Table 1  Bacterial strains and plasmids 646 
Strain/ Plasmid Description Source/ Reference 
S. aureus    
 NCDO949 Type strain, pleural fluid isolate Shinfield, UK 
 CUHT Pediatric Clinical Isolate, CUH clinic BRC 
 CUHE Pediatric Clinical Isolate, CUH clinic BRC 
 JKD6159 Dominant CA-MRSA strain in Australia, 
ST93-IV  
(Chua et al., 2010) 
 MW2 First community acquired CA-MRSA, ST1-
MRSA-IVa (2B) (pMW2) 
(Baba et al., 2002) 
 RN4220 Highly transformable restriction-minus 
derivate of NCTC8325-4 
(Kreiswirth et al., 
1983) 
E. coli    
 EPI300 Restriction-minus [mcrA, Δ(mcrCB-
hsdSMR-mrr)], recombination-minus 
(recA1), endonuclease-minus (endA1) 
Epicentre 
Plasmids    
 pBursa Encodes bursa aurealis transposable 
element, a temperature sensitive origin of 
replication, and chloramphenicol resistance 
selection marker 
(Bae et al., 2004) 
 pFA545 Encodes a transposase, origin of replication, 
and a tetracycline resistance selection marker 
(Bae et al., 2004) 
 pLI50 S. aureus (chloramphenicol resistance 
selection marker) / E. coli (ampicillin 
resistance selection marker) shuttle vector 
(Lee et al., 1991) 
 pLI50::int_tagHG pLI50 containing the tagG-tagH intergenic 
amplified from RN4220 genomic DNA 
using primers TagHGIntFor and 
TagHGIntRev and cloned as EcoRI-BamHI 
fragment 
This study 
 pLI50::tagG pLI50 containing tagG amplified from 
RN4220 genomic DNA using primers 
TagGForRBS and TagHGRev and cloned as 
EcoRI-BamHI fragment 
This study 
CA-MRSA, Community-acquired Methicillin‐resistant Staphylococcus aureus; ST, sequence type. 647 
 648 
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Table 2  Oligonucleotide sequences 649 
Primer name Sequence (5` - 3`) 
GFP1 TCCACTGACAGAAAATTTGTGCCCATTAAC 
GFP2 CATTAACATCACCATCTAATTCAACAAGAA 
GFP3 ACAAGAATTGGGACAACTCCAGTGA 
PF106 GACCACACGTCGACTAGTGCNNNNNNNNNNAGAG 
PF107 GACCACACGTCGACTAGTGCNNNNNNNNNNACGCC 
PF108 GACCACACGTCGACTAGTGCNNNNNNNNNNGATAC 
PF109 GACCACACGTCGACTAGTGC 
TagHGIntFor TAGTAAAGCTTGAATTCTTGTAGACCTTCCTTATTCACATT 
TagHGIntRev TAGTAGGATCCTCCATTAAACCACACTTTCAAATGT 
TagGForRBS TAGTAGAATTCTTAGGAGGATGATTATTTATGTCAGCAATAGGAACAG
TTTTT 
TagHGRev TAGTAGGATCCTTACAAGAAGTCTGCAAATTGATCTC 
 650 
Table 3  Effect of SC on the minimum inhibitory concentration of aminoglycosides in S. 651 
aureus.  652 
Antibiotic MIC 
0 mM SC 1 mM SC 
Gentamycin 4 µg/mL 0.5 µg/mL 
Streptomycin 16 µg/mL 8 µg/mL 
Neomycin 4 µg/mL 1 µg/mL 
Kanamycin 8 µg/mL 2 µg/mL 
The S. aureus RN4220 minimum inhibitory concentration of various aminoglycosides in the presence 653 
and absence of 1 mM SC is shown. 654 
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SUPPLEMENTARY FIGURES 656 
Fig. S1  Effect of 0.3% bile on antibiotic sensitivity in Staphylococcus aureus measured by 657 
disc diffusion testing. 658 
Fig. S2  Effect of sodium cholate on the growth of Staphylococcus aureus RN4220. Growth 659 
of S. aureus RN4220 in the presence of increasing concentrations of sodium cholate revealed that a 660 
concentration of 1 mM did not have any bacteriostatic or bactericidal effects on this strain. To determine 661 
the bacteriostatic effects of sodium cholate, a single colony of S. aureus was resuspended in 1 mL of 662 
TSB or TSB supplemented sodium cholate, and 200 µL aliquots transferred to a 96-well plate. The 663 
density of the S. aureus cells were quantified by measuring the absorbance at 600 nm following 664 
incubation at 37°C for 24 hours with agitation at 250 rpm. Two µL of the culture was subsequently 665 
dotted on to TSA plates and incubated at 37°C for 24 hours to determine the bactericidal effects of 666 
sodium cholate. Graph shows mean (+/- SD) absorbance of three replicates. Photographs show the 667 
bacterial growth resulting from the 2 µL culture on TSA. 668 
Fig. S3  Mutational analysis of the bile-induced biofilm response in S. aureus. S. aureus 669 
transposon mutants were cultured in TSB (untreated) or TSB supplemented with 0.3% bile. For each 670 
mutant biofilm formation is presented as Abs595nm in both treated and untreated samples. Graph shows 671 
the mean (+/- SD) absorbance of four biological replicates. 672 
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SUPPLEMENTARY TABLES 674 
Table S1  Genes disrupted in Staphylococcus aureus by transposon mutagenesis. 675 
Mutant Insertion 
Site a 
ORF b Putative Gene/Gene Product 
 
Gentamicin (0.5 μg/mL) and SC (1 mM) 
TM1 1775393 SAOUHSC_01868 Dipeptidase PepV 
TM2 1676550 SAOUHSC_01776 hemA; Glutamyl-tRNA reductase 
TM3 1444671 SAOUHSC_01488 Heptaprenyl pyrophosphate synthase subunit A 
 
Gentamicin (0.35 μg/mL) and SC (1 mM) 
TM4 630715 SAOUHSC_00641- tagH  
SAOUHSC_00642 tagG  
 
Gentamicin (0.3 μg/mL) and SC (1 mM) 
TM5 252438 SAOUHSC_00230 lytS; two-component sensor His-kinase 
TM6 205584 SAOUHSC_00186- ABC transporter substrate-binding 
SAOUHSC_00187 Pyruvate formate lyase 
TM7 814365 SAOUHSC_00843 ABC-transporter interface protein 
TM8 302717 SAOUHSC_00290 PTS system transporter 
TM9 1602302 SAOUHSC_01691 Competence protein ComEC/Rec2 
TM10 2605235 SAOUHSC_02826 MarR HTH regulator 
TM11 2385772 SAOUHSC_02595 Sodium bile acid transporter 
TM12 2083628 SAOUHSC_02247- ktrB; Potassium transporter  
SAOUHSC_02248 GNAT family acetyltransferase 
TM13 135192 SAOUHSC_00129 UDP-N-acetylglucosamine 2-epimerase 
TM14 1691106 SAOUHSC_01793- nrdR  
SAOUHSC_01794 Glyceraldehyde 3-phosphate dehydrogenase 
TM15 43138 SAOUHSC_00039 Dihydrouridine synthase 
TM16 1233041 SAOUHSC_01275 glpF; Glycerol uptake facilitator 
TM17 433362 SAOUHSC_00435 Glutamate synthase subunit 
TM18 2805147 SAOUHSC_03033 nixA; Nickel transporter 
TM19 1033768 SAOUHSC_01066 ctaB; heme O synthase 
TM20 2084622 SAOUHSC_02249 Membrane protein 
TM21 974315 SAOUHSC_01001 qoxB; Quinol oxidase subunit I 
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TM22 2807414 SAOUHSC_03035 Membrane protein 
 
Streptomycin (4 μg/mL) and SC (1 mM) 
TM23 2536967 SAOUHSC_02760 Glutamate synthase 
TM24 2007589 SAOUHSC_02133- nadC; Nicotinate phosphoribosyltransferase  
SAOUHSC_02134 Nitric oxide synthase oxygenase 
TM25 2604892 SAOUHSC_02825 Glyoxalase 
 
SDC (0.2 mM) 
TM26 241577 SAOUHSC_00221 tarJ; Ribitol-5-phosphate dehydrogenase 
TM27 2296822 SAOUHSC_02474 hypothetical protein 
TM28 2554107 SAOUHSC_02777 Probable D-galactonate transporter 
TM29 2004986 SAOUHSC_02131 hypothetical protein 
SAOUHSC_02132 NAD synthetase 
TM30 860206 SAOUHSC_00895 Glutamate dehydrogenase  
TM31 495319 SAOUHSC_R0007 Cell wall-associated hydrolase 
Neomycin (0.5 μg/mL) and SC (1 mM) 
TM36 136894 SAOUHSC_00131- Membrane spanning protein  
SAOUHSC_00132 Aldyhyde dehydrogenate 
 
Kanamycin (1.5 μg/mL) and SC (1 mM) 
TM39 744341 SAOUHSC_00760- gdpS  
SAOUHSC_00762 tagO 
TM40 44147 SAOUHSC_00040 Membrane protein 
TM41 1325036 SAOUHSC_01380- nikB; Nickel ABC transporter permease  
SAOUHSC_01381 Membrane protein 
TM42 2387891 SAOUHSC_02597 ptsG; Phosphotransferase system 
TM43 2075304 SAOUHSC_02239- Phage integrase  
SAOUHSC_02241 Leukocidin/Hemolysin toxin family 
TM44 2735026 SAOUHSC_02972 isaB; Immunodominant surface antigen B 
TM45 2598814 SAOUHSC_02820 ABC-2 transporter family protein 
TM46 71816 SAOUHSC_00067 lldP; L-lactate permease 
TM47 876020 SAOUHSC_00906 Fumarylacetoacetate (FAA) hydrolase family 
TM48 226300 SAOUHSC_00202- Uroporphyrinogen-III C-methyltransferase  
SAOUHSC_00203 Membrane protein 
TM49 1787295 SAOUHSC_01873 Hypothetical Protein 
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TM50 549173 SAOUHSC_00544 sdrC; Serine-aspartate repeat protein 
Transposon mutants are grouped according to antibiotic and/or bile acid concentrations used to screen 676 
for the mutant. a Genomic position in the NCTC8325 genome is presented. b Corresponding ORF in the 677 
NCTC8325 genome is presented.  678 
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